The triple therapy-activated tumor-infiltrating CTLs and NK cells and increased the production of TNF-α and IL-12, resulting in a significant inhibition of tumor growth and a total absence of lung metastasis in vivo [123]. The gene discussed is TNF; the disease is neoplasm.